VMware Inc. (NYSE: VMW) reported an 86% surge in earnings for the third quarter of 2020 driven by higher revenue as well as unrealized gain on an investment in Pivotal Software. The results exceeded analysts’ expectations.
Net income soared by 86% to $621 million or $1.50 per share. The latest quarter included an unrealized gain of $249 million on an investment in Pivotal Software. Adjusted earnings decreased by 4% to $1.49 per share.
Revenue grew by 12% to $2.46 billion. License revenue increased by 10% to $974 million. The results reflected broad-based strength across its product and solutions portfolio.
Hybrid Cloud Subscription and SaaS revenue grew to over 13% of total revenue in Q3, and the company expects this category to continue to grow significantly next year, including the contributions of Carbon Black and Pivotal.
For the third quarter, the company continued to see traction and customer momentum in support of VMware’s vision to deliver a software architecture that enables any app, on any cloud, delivered to any device. The company remained on track to close the acquisition of Pivotal Software by the end of the fiscal year.
For the quarter, software maintenance services revenue increased by 12.5% year-over-year to $1.28 billion. Professional services revenue grew by 13.5% to $202 million. Services accounted for 60% of the total revenue while license accounted for just 40%.
Cloud computing continues to be a rapidly growing market for VMware. And the company has been betting huge with several big acquisitions for driving product and market growth.
Most Popular
Darden Restaurants (DRI) Q2 2025 Earnings: Key financials and quarterly highlights
Darden Restaurants, Inc., (NYSE: DRI) reported its second quarter 2025 earnings results today. Total sales increased 6% year-over-year to $2.9 billion. Consolidated same-restaurant sales increased 2.4%. Net earnings were $215.1
MU Earnings: Highlights of Micron’s Q1 2025 report
Chipmaker Micron Technology Inc. (NASDAQ: MU) Wednesday announced financial results for the first quarter of 2025, reporting an increase in revenues. The company reported adjusted earnings of $1.79 per share
“Gelteq has been continuously evolving to expand applications and audiences”
Gelteq Limited (NASDAQ: GELS) is a healthcare company specializing in the development and manufacturing of edible gel products, with a focus on areas like pharmaceuticals, nutraceuticals, pet care, and sports
Comments
Comments are closed.